Evaluation of the Effectiveness of the Cardiostory Device in Distinguishing Heart Failure From Other Causes in Patients Presenting With Dyspnea. (CARDIOSTORY TN)
This is a prospective, observational study conducted in the emergency department. Adult patients presenting with dyspnea will be enrolled, and study data will be collected from routine clinical assessments, including medical history, physical examination, laboratory tests, and echocardiography results, as well as non-invasive cardiovascular measurements obtained using the CardioStory device.
研究概览
研究类型
注册 (估计的)
联系人和位置
学习地点
-
-
-
Sousse、突尼斯、4054
- 招聘中
- Sahloul university hospital
-
接触:
- Riadh Boukef, Professor
- 电话号码:+21698676745
- 邮箱:riadboukef@gmail.com
-
接触:
- Houda Chaouch, PhD
- 电话号码:97453468
- 邮箱:chawech_houda@yahoo.fr
-
首席研究员:
- Riadh Boukef, Professor
-
副研究员:
- Rahma Jaballah, University Hospital Assistant
-
-
Monastir Governorate
-
Monastir、Monastir Governorate、突尼斯、5000
- 招聘中
- Fattouma bourguiba university hospital
-
接触:
- Samir Nouira, Professor
- 电话号码:+21673106046
- 邮箱:semir.nouira.urg@gmail.com
-
接触:
- Houda Chaouch, PhD
- 电话号码:+21697453468
- 邮箱:chawech_houda@yahoo.fr
-
首席研究员:
- Samir Nouira, Professor
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
Adult patients presenting to the emergency department with acute or subacute dyspnea without an established diagnosis. This population represents patients requiring urgent evaluation to differentiate between cardiac and non-cardiac causes of dyspnea.
描述
Inclusion Criteria:
- Age ≥ 18 years
- Recent onset dyspnea (less than 7 days)
- Informed consent obtained
Exclusion Criteria:
- Age inferior to 18 years,
- Severe comorbidity, hemodynamic compromise or immediate need for mechanical ventilation were exclusion criteria.
- Dyspnea clearly of traumatic or allergic origin
学习计划
研究是如何设计的?
设计细节
- 观测模型:COHORT
- 时间观点:PROSPECTIVE
队列和干预
团体/队列 |
干预/治疗 |
|---|---|
|
Patients suffering from Dyspnea
Adult patients presenting to the emergency department with acute dyspnea. |
The CardioStory device, is a non-invasive medical technology designed to rapidly (approximately 2 minutes) assess cardiac filling pressure in patients with suspected or established heart failure. It uses proprietary fiber-optic sensors combined with advanced signal processing and analytical algorithms to detect and analyze physiological signals related to cardiac mechanical function. These signals are processed to generate a quantitative estimate of cardiac filling pressure without the need for catheterization, contrast agents, or injectable substances. The measurement is performed non-invasively and is designed to be simple, rapid, and reproducible. |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Diagnostic performance assessment of the CardioStory device.
大体时间:Day 1
|
To assess the diagnostic performance of the CardioStory device in differentiating patients with heart failure from those with non-cardiac causes of dyspnea (including respiratory, metabolic etiologies) in patients presenting to the emergency department, using standard clinical assessments as the reference standard. |
Day 1
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
To evaluate the sensitivity and specificity of the CardioStory device for the diagnosis of heart failure.
大体时间:Day 1
|
Day 1
|
|
|
To compare the diagnostic results obtained with CardioStory device with reference diagnostic tools
大体时间:Day 1
|
Evaluating the correlation between CardioStory-derived cardiac filling pressures and NT-proBNP levels, as well as the correlation between CardioStory measurements and echocardiography-derived parameters of cardiac function |
Day 1
|
|
To evaluate the time required to obtain measurements using the CardioStory device compared with standard clinical assessments.
大体时间:Day 1
|
Time (in minutes) from initiation of the CardioStory measurement to availability of the diagnostic result, compared with the time required for standard clinical assessments. |
Day 1
|
|
To assess the adverse event occurrences of the CardioStory device in the emergency setting.
大体时间:Day 1
|
Safety data will be collected for all participants. Any adverses event occurring within 30 min to 24 hours after the use of the CardioStory device will be documented and recorded |
Day 1
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
关键字
其他研究编号
- CS-HF_DYSP-2025
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
在美国制造并从美国出口的产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.